Why Biology Is Not Destiny
By M.W. Feldman and Jessica Riskin,
The New York Review
| 04. 21. 2022
You must know the parable about the frog that sits in a pot of water being gradually heated, allowing itself to be boiled alive: because the change happens gradually, it never realizes it should leap out. Reading Kathryn Paige Harden’s book The Genetic Lottery: Why DNA Matters for Social Equality is a similar experience, as the author ingenuously points out. “Like a frog being slowly boiled alive,” she observes, readers follow her argument “from an uncontroversial premise to a highly controversial one.” Harden’s “uncontroversial premise” in this case is that siblings raised in the same family share a childhood environment and 50 percent of their DNA randomly assigned at conception, and are therefore like subjects in a controlled study of genetic differences. Ask anyone with a sibling whether their own childhood environment was the same as their sibling’s and you’ll quickly disprove Harden’s claim that her premise is uncontroversial. But putting that objection aside and sitting patiently as Harden increases the heat, we’ll arrive at her “highly controversial” assertion that “if siblings who differ genetically also have corresponding differences in...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...
By Emily Mullin, Wired | 10.30.2025
In 2018, Chinese scientist He Jiankui shocked the world when he revealed that he had created the first gene-edited babies. Using Crispr, he tweaked the genes of three human embryos in an attempt to make them immune to HIV and...